China Pharma Holdings (CPHI) Debt Ratio (2010 - 2026)

China Pharma Holdings' Debt Ratio history runs 17 years deep, the most recent figure standing at 0.03 for Q1 2026.

• Quarterly Debt Ratio fell 80.21% year-over-year to 0.03 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03 (down 80.21% YoY) and the FY2025 annual result came in at 0.05, down 72.82% from the prior year.
• Debt Ratio was 0.03 for Q1 2026 at China Pharma Holdings, down from 0.05 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.28 in Q3 2022 and bottomed at 0.03 in Q1 2026.
• A 5-year average of 0.16 and a median of 0.17 in 2024 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio soared 222.38% — and 2026, when it slumped 80.21%.
• China Pharma Holdings' Debt Ratio stood at 0.14 in 2022, then grew by 12.62% to 0.15 in 2023, then advanced by 10.21% to 0.17 in 2024, then tumbled by 72.82% to 0.05 in 2025, then decreased by 29.85% to 0.03 in 2026.
• Business Quant data shows CPHI's Debt Ratio at 0.03 in Q1 2026, 0.05 in Q4 2025, and 0.12 in Q3 2025.